Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Twist Bioscience Corporation    TWST

TWIST BIOSCIENCE CORPORATION

(TWST)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
88.76(c) 86.23(c) 87.06(c) 85.97(c) 82.58(c) Last
627 445 553 010 775 050 581 664 461 459 Volume
-4.56% -2.85% +0.96% -1.25% -3.94% Change
More quotes
Financials (USD)
Sales 2020 80,3 M - -
Net income 2020 -147 M - -
Net cash position 2020 328 M - -
P/E ratio 2020 -22,1x
Yield 2020 -
Sales 2021 118 M - -
Net income 2021 -84,6 M - -
Net cash position 2021 272 M - -
P/E ratio 2021 -39,7x
Yield 2021 -
Capitalization 3 688 M 3 688 M -
EV / Sales 2020 41,8x
EV / Sales 2021 28,9x
Nbr of Employees 414
Free-Float 91,4%
More Financials
Company
Twist Bioscience Corporation is a synthetic biology company. The Company is developing a disruptive deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company has a semiconductor-based synthetic DNA manufacturing process featuring 10,000-well silicon platform, which is capable of producing synthetic biology tools, such as genes, oligonucleotide pools and variant libraries. 
Sector
Pharmaceuticals
Calendar
12/16Earnings Release
More about the company
Notations Surperformance© of Twist Bioscience Corporation
Trading Rating : Investor Rating :
More Ratings
All news about TWIST BIOSCIENCE CORPORATION
08:03aTWIST BIOSCIENCE : Collaborates With Beyond Earth to Launch Artwork Stored in DN..
BU
10/13TWIST BIOSCIENCE : to Host Virtual Biopharma Analyst & Investor Event on October..
BU
10/13TWIST BIOSCIENCE : and Neogene Announce Broad Strategic Partnership for Next Gen..
BU
09/18TWIST BIOSCIENCE : Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin Awar..
BU
09/03TWIST BIOSCIENCE : to Present at Upcoming Virtual Investor Conferences
BU
09/02TWIST BIOSCIENCE : Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 T..
BU
08/20TWIST BIOSCIENCE : Synthetic DNA Stores New Netflix Original Series ‘BIOHA..
BU
08/06TWIST BIOSCIENCE : Fiscal 3Q Earnings Snapshot
AQ
08/06TWIST BIOSCIENCE CORP : Results of Operations and Financial Condition, Financial..
AQ
08/06TWIST BIOSCIENCE : Reports Third Quarter Fiscal 2020 Financial Results
BU
08/04TWIST BIOSCIENCE : Seismic Bio Partners With Twist Bioscience for Discovery and ..
BU
07/30TWIST BIOSCIENCE : to Report Fiscal 2020 Third Quarter Financial Results on Thur..
BU
07/28TWIST BIOSCIENCE : Launches Two SARS-CoV-2 Antibody Panels to Expedite Research ..
BU
07/23TWIST BIOSCIENCE : Appoints Erin Smith Senior Vice President, Government Affairs..
BU
07/22TWIST BIOSCIENCE : Launches Synthetic Controls for Respiratory Viruses
BU
More news
News in other languages on TWIST BIOSCIENCE CORPORATION
2019TWIST BIOSCIENCE : Le consortium regroupant la Fondation Praesens, l'Institut Pa..
2019TWIST BIOSCIENCE :  Bioscience et iGEM s'associent pour fournir de l'ADN synthét..
More news
Chart TWIST BIOSCIENCE CORPORATION
Duration : Period :
Twist Bioscience Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TWIST BIOSCIENCE CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 80,00 $
Last Close Price 82,58 $
Spread / Highest target 8,99%
Spread / Average Target -3,12%
Spread / Lowest Target -15,2%
EPS Revisions
Managers
NameTitle
Emily Marine Leproust Chairman, President & Chief Executive Officer
Patrick Weiss Chief Operating Officer
James M. Thorburn Chief Financial Officer
Bill James Peck Chief Technology Officer
Aaron K. Sato Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TWIST BIOSCIENCE CORPORATION293.24%3 688
CSL LIMITED7.34%95 933
BIOGEN INC.-13.37%39 557
WUXI BIOLOGICS (CAYMAN) INC.121.59%38 375
SAMSUNG BIOLOGICS CO.,LTD.45.50%36 786
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.186.79%33 950